Methylphenidate speeds evaluation processes of attention deficit disorder adolescents during a continuous performance test
- PMID: 1865045
- DOI: 10.1007/BF00911231
Methylphenidate speeds evaluation processes of attention deficit disorder adolescents during a continuous performance test
Abstract
Forty-six Attention Deficit Disorder (ADD) adolescents took a Continuous Performance Test (CPT) under placebo and methylphenidate (35.33 mg/day). The task required pressing one button for targets (p = .133), and another button for nontargets. Subjects displayed a strong bias to make the more frequent negative response before completely evaluating stimuli. Consistent with this assumption, subjects responded faster (by an average of 87 ms) to nontargets than to targets. Methylphenidate increased accuracy and speeded reaction times (RTs) to targets. The drug also increased the amplitude of the P3b component of the event-related potential for nontargets and shortened the latency of P3b for both targets and nontargets. These results suggest increased capacity allocation to and faster evaluation of task stimuli. Finally, the stimulant lengthened relative motor processing time (RT-P3b latency) for nontargets, a finding implying that response processing was accomplished with the benefit of earlier completion of evaluation processes for these stimuli.
Similar articles
-
Methylphenidate influences on both early and late ERP waves of ADHD children in a continuous performance test.J Abnorm Child Psychol. 1994 Oct;22(5):561-78. doi: 10.1007/BF02168938. J Abnorm Child Psychol. 1994. PMID: 7822629 Clinical Trial.
-
Methylphenidate reduces abnormalities of stimulus classification in adolescents with attention deficit disorder.J Abnorm Psychol. 1992 Feb;101(1):130-8. doi: 10.1037//0021-843x.101.1.130. J Abnorm Psychol. 1992. PMID: 1537959 Clinical Trial.
-
Clinical and cognitive effects of methylphenidate on children with attention deficit disorder as a function of aggression/oppositionality and age.J Abnorm Psychol. 1994 May;103(2):206-21. doi: 10.1037//0021-843x.103.2.206. J Abnorm Psychol. 1994. PMID: 8040490 Clinical Trial.
-
Methylphenidate does not modify the impact of response frequency or stimulus sequence on performance and event-related potentials of children with attention deficit hyperactivity disorder.J Abnorm Child Psychol. 1998 Aug;26(4):233-45. doi: 10.1023/a:1022698232481. J Abnorm Child Psychol. 1998. PMID: 9700516 Clinical Trial.
-
Cognitive event-related potentials in attention deficit disorder.J Learn Disabil. 1991 Mar;24(3):130-40. doi: 10.1177/002221949102400301. J Learn Disabil. 1991. PMID: 2026954 Review.
Cited by
-
Effects of methylphenidate on quantitative EEG of boys with attention-deficit hyperactivity disorder in continuous performance test.Yonsei Med J. 2005 Feb 28;46(1):34-41. doi: 10.3349/ymj.2005.46.1.34. Yonsei Med J. 2005. PMID: 15744803 Free PMC article. Clinical Trial.
-
Prenatal PCB exposure, the corpus callosum, and response inhibition.Environ Health Perspect. 2003 Oct;111(13):1670-7. doi: 10.1289/ehp.6173. Environ Health Perspect. 2003. PMID: 14527849 Free PMC article.
-
The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders.Br J Pharmacol. 2011 Oct;164(4):1301-21. doi: 10.1111/j.1476-5381.2011.01323.x. Br J Pharmacol. 2011. PMID: 21410459 Free PMC article. Review.
-
Response variability in Attention-Deficit/Hyperactivity Disorder: a neuronal and glial energetics hypothesis.Behav Brain Funct. 2006 Aug 23;2:30. doi: 10.1186/1744-9081-2-30. Behav Brain Funct. 2006. PMID: 16925830 Free PMC article.
-
Attention Deficit Hyperactivity Disorder.Curr Treat Options Neurol. 2001 May;3(3):229-236. doi: 10.1007/s11940-001-0004-y. Curr Treat Options Neurol. 2001. PMID: 11282038
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical